Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients

Joint Bone Spine

Volumn 84, Issue 2, 2017, Pages 159-162

  Abbara, Salam ^a   Georgin Lavialle, Sophie ^a,b   Stankovic Stojanovic, Katia ^a   Bachmeyer, Claude ^a   Senet, Patricia ^a   Buob, David ^a   Audia, Sylvain ^c   Delcey, Véronique ^d   Fellahi, Soraya ^a   Bastard, Jean Philippe ^a   Awad, Fawaz ^b,e   Legendre, Marie ^e   Amselem, Serge ^a,b,e   Grateau, Gilles ^a,b  

^a HÔPITAL TENON   (France)

^b Assistance publique Hôpitaux de Paris   (France)

^c Service de médecine interne et immunologie clinique   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Autoinflammatory syndrome; Colchicine; Familial Mediterranean fever; Hidradenitis suppurativa; Interleukin 1 inhibitors; MEFV

Indexed keywords

ACUTE PHASE PROTEIN; ANAKINRA; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; COLCHICINE;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL OUTCOME; DISEASE ASSOCIATION; DRUG DOSE INCREASE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MEFV GENE; MIDDLE AGED; NEPHROTIC SYNDROME; SALIVARY GLAND BIOPSY; SCREENING; SUPPURATIVE HIDRADENITIS; CASE REPORT; COMPLICATION;

ADULT; AGED; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED;

EID: 84969752767     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2016.02.021     Document Type: Article

References (15)

1. [1] Ben-Chetrit, E., Levy, M., Familial Mediterranean fever. Lancet 351 (1998), 659–664.
2. [2] Soriano, A., Verecchia, E., Afeltra, A., et al. IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol 45 (2013), 117–130.
3. [3] Collier, F., Smith, R.C., Morton, C.A., Diagnosis and management of hidradenitis suppurativa. BMJ, 346, 2013, f2121.
4. [4] Girouard, S.D., Falk, R.H., Rennke, H.G., et al. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J, 18, 2012, 2.
5. [5] Livneh, A., Langevitz, P., Zemer, D., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40 (1997), 1879–1885.
6. [6] Zouboulis, C., Desai, N., Emtestam, L., et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 29 (2015), 619–644.
7. [7] Jéru, I., Hentgen, V., Cochet, E., et al. The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach. PloS One, 8, 2013, e68431.
8. [8] Grateau, G., Hentgen, V., Stojanovic, K.S., et al. How should we approach classification of autoinflammatory diseases?. Nat Rev Rheumatol 9 (2013), 624–629.
9. [9] Kelly, G., Sweeney, C.M., Tobin, A.-M., et al. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol 53 (2014), 1186–1196.
10. [10] Hsiao, J.L., Antaya, R.J., Berger, T., et al. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol 146 (2010), 1265–1270.
11. [11] Garzorz, N., Papanagiotou, V., Atenhan, A., et al. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?. J Eur Acad Dermatol Venereol 30 (2016), 141–143.
12. [12] Bruzzese, V., Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 18 (2012), 413–415.
13. [13] Richette, P., Molto, A., Viguier, M., et al. Hidradenitis suppurativa associated with spondyloarthritis – results from a multicenter national prospective study. J Rheumatol 41 (2014), 490–494.
14. [14] Zarchi, K., Dufour, D.N., Jemec, G.B.E., Successful treatment of severe hidradenitis suppurativa with anakinra. JAMA Dermatol 149 (2013), 1192–1194.
15. [15] Leslie, K.S., Tripathi, S.V., Nguyen, T.V., et al. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. J Am Acad Dermatol 70 (2014), 243–251.